caffeine has been researched along with Birth Weight in 107 studies
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylxanthines, including caffeine, theophylline, and aminophylline, work as stimulants of the respiratory drive, and decrease apnea of prematurity, a developmental disorder common in preterm infants." | 9.41 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Marques, KA; Moresco, L; Sjögren, A; Soll, R, 2023) |
| "Preterm infants with apnea who were born at less than 32 weeks of gestational age and birth weight ≤1500 g were randomly divided into caffeine citrate prevention group and caffeine citrate treatment group." | 9.34 | Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea. ( Gao, Z; Han, D; Kou, C; Li, Z; Liu, Z; Wu, W; Zhang, Y, 2020) |
| "Caffeine therapy for apnea of prematurity did not significantly reduce the combined rate of academic, motor, and behavioral impairments but was associated with a reduced risk of motor impairment in 11-year-old children with very low birth weight." | 9.24 | Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial. ( Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2017) |
| "To evaluate the effectiveness and safety of different doses of caffeine in treatment of primary apnea in preterm infants." | 9.22 | [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants]. ( Liu, G; Tian, X; Zhao, Y, 2016) |
| "This retrospective study reviewed weight gain, time to reach full feeds and time to cease caffeine in PBs previously enrolled in the RCT." | 9.19 | CeasIng Cpap At standarD criteriA (CICADA): impact on weight gain, time to full feeds and caffeine use. ( Abdel-Latif, ME; Broom, M; Shadbolt, B; Stewart, A; Todd, DA; Wright, A; Ying, L, 2014) |
| "To estimate the effect of reducing caffeine intake during pregnancy on birth weight and length of gestation." | 9.12 | Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. ( Bech, BH; Henriksen, TB; Obel, C; Olsen, J, 2007) |
| "Fifteen infants, median gestational age at birth 27 weeks (range 24-30), age at study 27 days (12-60), with >/=6 episodes of bradycardia or hypoxaemia/6 h despite serum caffeine levels in the therapeutic range, received doxapram either intravenously (0." | 9.09 | Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. ( Bohnhorst, B; Darraj, S; Poets, CF, 1999) |
| " Reducing caffeinated coffee consumption by 180 mg of caffeine (the equivalent of 2 cups) per day after 16 weeks' gestation doesn't affect birth weight." | 8.93 | Clinical Inquiry: Does caffeine intake during pregnancy affect birth weight? ( Adams, T; Kelsberg, G; Safranek, S, 2016) |
| "Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes." | 8.91 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. ( Jaafar, SH; Jahanfar, S, 2015) |
| "Epidemiologic studies have shown inconsistent conclusions about the effect of caffeine intake during pregnancy on the risk of low birth weight (LBW)." | 8.91 | Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies. ( Keum, N; Kim, R; Kim, Y; Lai, Y; Oldenburg, CE; Rhee, J; Tam, M, 2015) |
| " It is thanks to the efforts of Barbara Schmidt and the Caffeine for Apnea of Prematurity (CAP) Trial Group that we now have high-quality and reliable data not only on short-term but also long-term outcomes of caffeine use for apnea of prematurity." | 8.90 | Caffeine for apnea of prematurity: a neonatal success story. ( Bassler, D; Kreutzer, K, 2014) |
| "Caffeine is commonly consumed during pregnancy, crosses the placenta, with fetal serum concentrations similar to the mother's, but studies of birth outcome show conflicting findings." | 8.90 | Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. ( Cade, JE; Garrard, L; Greenwood, DC; Keogh, G; King, LG; Thatcher, NJ; Ye, J, 2014) |
| "Considerable controversy exists regarding the relation between maternal caffeine intake during pregnancy and risk of low birth weight (birth weight <2,500 g)." | 8.90 | Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis. ( Chen, LW; Chong, MF; Neelakantan, N; Pan, A; van Dam, RM; Wu, Y, 2014) |
| "Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes." | 8.89 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. ( Jaafar, SH; Jahanfar, S, 2013) |
| "Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes." | 8.85 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. ( Jahanfar, S; Sharifah, H, 2009) |
| "The half-life decreased and the weight-adjusted clearance increased more significantly in neonates with lower birth weights, resulting in lower caffeine plasma concentrations." | 8.31 | Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. ( Johnson, PN; Lim, SY; May, CB; Miller, JL, 2023) |
| "To determine whether prophylactic caffeine and ibuprofen, which have been shown to have vascular endothelial growth factor-modulating properties in other contexts, have a detectable effect on the incidence of severe retinopathy of prematurity (ROP) when administered in extremely low birth weight infants during the first 48 hours of life." | 8.02 | The effect of ibuprofen and caffeine prophylaxis on retinopathy of prematurity. ( Bhatt-Mehta, V; Schumacher, RE, 2021) |
| "The aims of this study were to identify: (i) the proportion of women exceeding the caffeine intake guideline (>200 mg/day) during each trimester, accounting for point of pregnancy awareness; (ii) guideline adherence trajectories across pregnancy; (iii) maternal characteristics associated with trajectories; and (iv) association between adherence and growth restriction birth outcomes." | 7.88 | Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort Study. ( Allsop, S; Bruno, R; Burns, L; Elliott, E; Hutchinson, D; Mattick, RP; McCormack, C; Olsson, CA; Peacock, A; Wilson, J, 2018) |
| "Incidence fell from 74% diagnosed with apnea of prematurity at baseline to 49% diagnosed with CSCPE postimplementation (P<0." | 7.85 | Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management. ( Ahlers-Schmidt, CR; Bloom, BT; Engel, M; Powell, MB, 2017) |
| "The associations of maternal caffeine intake during pregnancy with offspring growth patterns and body fat and insulin levels at school age were examined." | 7.83 | Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. ( Franco, OH; Gaillard, R; Gishti, O; Hofman, A; Jaddoe, VW; Voerman, E, 2016) |
| "there was no difference in caffeine consumption in pregnant women with birth weight ≥2 500 g and." | 7.81 | PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION. ( Bueno-Cavanillas, A; Del Castillo, N; Jiménez-Moleón, JJ; Martínez-Ruiz, V; Mozas, J; Olmedo-Requena, R, 2015) |
| " All patients were evaluated for factors associated with the development of NEC including exposure to caffeine (dosing and duration), gestational age, birth weight, vasoactive medications and maternal illicit drug use." | 7.81 | Evaluation of caffeine and the development of necrotizing enterocolitis. ( Bookstaver, PB; Cox, C; Hashem, NG; Iskersky, V; Tebbs, J, 2015) |
| "Estimation of the maternal caffeine intake during pregnancy and its influence on pregnancy duration, birthweight and Apgar score of the newborn." | 7.78 | Maternal caffeine intake and its effect on pregnancy outcomes. ( Jarosz, M; Siuba, M; Wierzejska, R, 2012) |
| "Outside pregnancy, acute caffeine consumption is associated with insulin resistance." | 7.77 | Caffeine and insulin resistance in pregnancy. ( Catov, J; Laughon, SK; Parana, S; Powers, RW; Roberts, JM, 2011) |
| "To examine the association of maternal caffeine intake with fetal growth restriction." | 7.74 | Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. ( , 2008) |
| "Apnea of prematurity develop during the first days of life and usually resolve by the time the infant reaches 36-37 weeks postmenstrual age." | 7.73 | [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate]. ( Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F, 2006) |
| "The aim of this study was to determine the effects of tobacco use and consumption of caffeine in pregnancy on the fetus and placenta by measuring the body weights, head circumferences, and lengths of newborns, and also weights and diameters of placentas." | 7.72 | The effect of smoking and caffeine on the fetus and placenta in pregnancy. ( Balat, A; Balat, O; Pençe, S; Ugur, MG, 2003) |
| "To test the hypothesis that, in women with type 1 diabetes, prenatal smoking and caffeine consumption during pregnancy are associated with an increased risk of adverse maternal and perinatal outcomes." | 7.72 | Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. ( Buncher, CR; Kalkwarf, H; Khoury, JC; Khoury, PR; McElvy, S; Miodovnik, M; Sibai, B, 2004) |
| "Epidemiologic studies have been unable to conclusively evaluate whether caffeine intake during pregnancy is associated with reduced birth weight and/or fetal growth restriction." | 7.71 | Effect of caffeine exposure during pregnancy on birth weight and gestational age. ( Clausson, B; Cnattingius, S; Ekbom, A; Granath, F; Lundgren, S; Nordmark, A; Signorello, LB, 2002) |
| "The authors conducted a matched case-control study to investigate the effects of caffeine intake during pregnancy on birth weight." | 7.70 | Caffeine intake and low birth weight: a population-based case-control study. ( Carvalhal, JB; Huttly, S; Santos, IS; Victora, CG, 1998) |
| "To examine the association of plasma caffeine concentrations during pregnancy with fetal growth and to compare this with relations with reported caffeine intake." | 7.69 | Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study. ( Anderson, HR; Bland, JM; Carey, IM; Cook, DG; Feyerabend, C; Jarvis, MJ; Peacock, JL, 1996) |
| "The aim of this study was to examine the effect of caffeine consumption during pregnancy on birth weight and its possible interaction with smoking." | 7.69 | Effect of caffeine intake during pregnancy on birth weight. ( Adanja, BJ; Marinković, JM; Petrović, RR; Sipetić, SB; Vlajinac, HD, 1997) |
| "The aim of this study was to investigate the effect of alcohol and caffeine consumption on birth weight and the possible interaction of these substances with smoking." | 7.68 | Effects of birth weight of alcohol and caffeine consumption during pregnancy. ( Dehaene, P; Kaminski, M; Larroque, B; Lelong, N; Subtil, D, 1993) |
| "Whether caffeine intake during pregnancy is related to intrauterine growth retardation, low birth weight, and preterm birth remains unclear." | 7.68 | Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth. ( Beaulac-Baillargeon, L; Fortier, I; Marcoux, S, 1993) |
| "To assess the prevalence of smoking and of caffeine and alcohol intake during pregnancy in a northern population and to determine the relation of these factors to birth weight, length and head circumference." | 7.68 | Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth. ( Froese, GJ; Godel, JC; Hodges, PE; Joffres, MR; Johnson, KE; Pabst, HF, 1992) |
| "Mice were administered caffeine (500 mg/liter of drinking water) from d 1 until d 18 of pregnancy." | 7.68 | Caffeine administered during pregnancy augments subsequent lactation in mice. ( Sheffield, LG, 1991) |
| "Taken together with studies reporting similar findings, these results suggest that heavy caffeine consumption increases the risk for fetal growth retardation." | 7.68 | Caffeine consumption during pregnancy and fetal growth. ( Eskenazi, B; Fenster, L; Swan, SH; Windham, GC, 1991) |
| "To investigate the effects of smoking, alcohol, and caffeine consumption and socio-economic factors and psychosocial stress on birth weight." | 7.67 | Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. ( Anderson, HR; Bland, JM; Brooke, OG; Peacock, JL; Stewart, CM, 1989) |
| "Caffeine, when administered in moderate (30 mg/kg X d) or high (60 mg/kg X d) doses during pregnancy, was shown to cause significant fetal growth retardation of both sexes." | 7.67 | Effects of caffeine administered during pregnancy on fetal development and subsequent function in the adult rat: prolonged effects on a second generation. ( Jabbour, H; Mehrabani, PA; Pollard, I, 1987) |
| "To evaluate the relationship of antecedent maternal smoking and caffeine consumption habits on the occurrence of apnea in their offspring, rates for central and obstructive apnea were analyzed in a cohort of mother-infant pairs." | 7.67 | Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study. ( Bendell, D; Duke, JC; Mattice, CD; McCaffree, MA; Orr, WC; Toubas, PL, 1986) |
| "Use of alcohol, caffeine, and nicotine during pregnancy can have serious consequences for the fetus, such as low birth weight, congenital anomalies, or even death." | 7.66 | Alcohol, caffeine, and nicotine as factors in pregnancy. ( Lodge, JR; Weathersbee, PS, 1979) |
| "Caffeine treatment is routinely used in premature infants to prevent development of apnea and bronchopulmonary dysplasia." | 7.30 | Effects of Different Onset Times of Early Caffeine Treatment on Mesenteric Tissue Oxygenation and Necrotizing Enterocolitis: A Prospective, Randomized Study. ( Cakir, SC; Cetinkaya, M; Koksal, N; Ozkan, H; Saglam, O, 2023) |
| "Caffeine exposure was associated to SGA (OR = 1." | 5.51 | Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome - results from the Norwegian Mother and Child Cohort Study. ( Bellocco, R; Brantsæter, AL; Elfvin, A; Jacobsson, B; Meltzer, HM; Modzelewska, D; Sengpiel, V, 2019) |
| "Methylxanthines, including caffeine, theophylline, and aminophylline, work as stimulants of the respiratory drive, and decrease apnea of prematurity, a developmental disorder common in preterm infants." | 5.41 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Marques, KA; Moresco, L; Sjögren, A; Soll, R, 2023) |
| "Caffeine intake was consistently associated with decreased BW and increased odds of SGA." | 5.39 | Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. ( Alexander, J; Bacelis, J; Brantsaeter, AL; Elind, E; Grove, J; Haugen, M; Jacobsson, B; Meltzer, HM; Myhre, R; Nilsson, S; Sengpiel, V, 2013) |
| "Preterm infants with apnea who were born at less than 32 weeks of gestational age and birth weight ≤1500 g were randomly divided into caffeine citrate prevention group and caffeine citrate treatment group." | 5.34 | Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea. ( Gao, Z; Han, D; Kou, C; Li, Z; Liu, Z; Wu, W; Zhang, Y, 2020) |
| "Caffeine therapy for apnea of prematurity did not significantly reduce the combined rate of academic, motor, and behavioral impairments but was associated with a reduced risk of motor impairment in 11-year-old children with very low birth weight." | 5.24 | Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial. ( Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2017) |
| "To evaluate the effectiveness and safety of different doses of caffeine in treatment of primary apnea in preterm infants." | 5.22 | [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants]. ( Liu, G; Tian, X; Zhao, Y, 2016) |
| "This retrospective study reviewed weight gain, time to reach full feeds and time to cease caffeine in PBs previously enrolled in the RCT." | 5.19 | CeasIng Cpap At standarD criteriA (CICADA): impact on weight gain, time to full feeds and caffeine use. ( Abdel-Latif, ME; Broom, M; Shadbolt, B; Stewart, A; Todd, DA; Wright, A; Ying, L, 2014) |
| "To estimate the effect of reducing caffeine intake during pregnancy on birth weight and length of gestation." | 5.12 | Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. ( Bech, BH; Henriksen, TB; Obel, C; Olsen, J, 2007) |
| "Fifteen infants, median gestational age at birth 27 weeks (range 24-30), age at study 27 days (12-60), with >/=6 episodes of bradycardia or hypoxaemia/6 h despite serum caffeine levels in the therapeutic range, received doxapram either intravenously (0." | 5.09 | Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. ( Bohnhorst, B; Darraj, S; Poets, CF, 1999) |
| "Preterm infants with a gestational age of <32 weeks and birth weight of <1,500 g were randomized to receive either caffeine or aminophylline treatment for apnea of prematurity." | 5.09 | Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment. ( Bertini, G; Dani, C; Martelli, E; Reali, MF; Rubaltelli, FF; Tronchin, M; Wiechmann, L, 2000) |
| " Reducing caffeinated coffee consumption by 180 mg of caffeine (the equivalent of 2 cups) per day after 16 weeks' gestation doesn't affect birth weight." | 4.93 | Clinical Inquiry: Does caffeine intake during pregnancy affect birth weight? ( Adams, T; Kelsberg, G; Safranek, S, 2016) |
| "Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes." | 4.91 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. ( Jaafar, SH; Jahanfar, S, 2015) |
| " It is thanks to the efforts of Barbara Schmidt and the Caffeine for Apnea of Prematurity (CAP) Trial Group that we now have high-quality and reliable data not only on short-term but also long-term outcomes of caffeine use for apnea of prematurity." | 4.90 | Caffeine for apnea of prematurity: a neonatal success story. ( Bassler, D; Kreutzer, K, 2014) |
| "Caffeine is commonly consumed during pregnancy, crosses the placenta, with fetal serum concentrations similar to the mother's, but studies of birth outcome show conflicting findings." | 4.90 | Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. ( Cade, JE; Garrard, L; Greenwood, DC; Keogh, G; King, LG; Thatcher, NJ; Ye, J, 2014) |
| "Considerable controversy exists regarding the relation between maternal caffeine intake during pregnancy and risk of low birth weight (birth weight <2,500 g)." | 4.90 | Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis. ( Chen, LW; Chong, MF; Neelakantan, N; Pan, A; van Dam, RM; Wu, Y, 2014) |
| "Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes." | 4.89 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. ( Jaafar, SH; Jahanfar, S, 2013) |
| "Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes." | 4.85 | Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. ( Jahanfar, S; Sharifah, H, 2009) |
| "The half-life decreased and the weight-adjusted clearance increased more significantly in neonates with lower birth weights, resulting in lower caffeine plasma concentrations." | 4.31 | Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. ( Johnson, PN; Lim, SY; May, CB; Miller, JL, 2023) |
| "Caffeine consumption during pregnancy has effect on newborn anthropometry therefore the amount of maternal caffeine consumption is important." | 4.12 | The caffeine consumption among Turkish pregnant women. ( Apay, SE; Cil, MA; Gur, EY, 2022) |
| "To determine whether prophylactic caffeine and ibuprofen, which have been shown to have vascular endothelial growth factor-modulating properties in other contexts, have a detectable effect on the incidence of severe retinopathy of prematurity (ROP) when administered in extremely low birth weight infants during the first 48 hours of life." | 4.02 | The effect of ibuprofen and caffeine prophylaxis on retinopathy of prematurity. ( Bhatt-Mehta, V; Schumacher, RE, 2021) |
| "Higher caffeine consumption during pregnancy has been associated with lower birth weight." | 4.02 | Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons. ( Amyx, M; Bever, AM; Buck Louis, GM; Gerlanc, N; Gleason, JL; Grantz, KL; Hinkle, SN; Kannan, K; Robinson, M; Smarr, MM; Sundaram, R; Tekola-Ayele, F; Vafai, Y, 2021) |
| "The aims of this study were to identify: (i) the proportion of women exceeding the caffeine intake guideline (>200 mg/day) during each trimester, accounting for point of pregnancy awareness; (ii) guideline adherence trajectories across pregnancy; (iii) maternal characteristics associated with trajectories; and (iv) association between adherence and growth restriction birth outcomes." | 3.88 | Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort Study. ( Allsop, S; Bruno, R; Burns, L; Elliott, E; Hutchinson, D; Mattick, RP; McCormack, C; Olsson, CA; Peacock, A; Wilson, J, 2018) |
| "Incidence fell from 74% diagnosed with apnea of prematurity at baseline to 49% diagnosed with CSCPE postimplementation (P<0." | 3.85 | Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management. ( Ahlers-Schmidt, CR; Bloom, BT; Engel, M; Powell, MB, 2017) |
| "The associations of maternal caffeine intake during pregnancy with offspring growth patterns and body fat and insulin levels at school age were examined." | 3.83 | Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. ( Franco, OH; Gaillard, R; Gishti, O; Hofman, A; Jaddoe, VW; Voerman, E, 2016) |
| "there was no difference in caffeine consumption in pregnant women with birth weight ≥2 500 g and." | 3.81 | PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION. ( Bueno-Cavanillas, A; Del Castillo, N; Jiménez-Moleón, JJ; Martínez-Ruiz, V; Mozas, J; Olmedo-Requena, R, 2015) |
| " All patients were evaluated for factors associated with the development of NEC including exposure to caffeine (dosing and duration), gestational age, birth weight, vasoactive medications and maternal illicit drug use." | 3.81 | Evaluation of caffeine and the development of necrotizing enterocolitis. ( Bookstaver, PB; Cox, C; Hashem, NG; Iskersky, V; Tebbs, J, 2015) |
| "Maternal caffeine exposure may be one of the causes for intrauterine growth retardation and low birth weight (LBW), and increased risk of type 2 diabetes mellitus (T2DM) in the adulthood has been associated with LBW." | 3.80 | Maternal caffeine exposure impairs insulin secretion by pancreatic β-cells and increases the risk of type II diabetes mellitus in offspring. ( Chan, HC; Chen, H; Guo, J; Huang, X; Jiang, X; Sha, J; Sun, T; Wang, F; Xu, Z; Zhang, J; Zhang, X, 2014) |
| "Three hundred and thirty-eight DBS cards for caffeine measurement were collected from 67 preterm infants (birth weight 0." | 3.79 | Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants. ( Della Pasqua, O; Field, DJ; Gade, S; Kairamkonda, V; Mulla, H; Pandya, HC; Patel, P; Spooner, N, 2013) |
| "Estimation of the maternal caffeine intake during pregnancy and its influence on pregnancy duration, birthweight and Apgar score of the newborn." | 3.78 | Maternal caffeine intake and its effect on pregnancy outcomes. ( Jarosz, M; Siuba, M; Wierzejska, R, 2012) |
| "Outside pregnancy, acute caffeine consumption is associated with insulin resistance." | 3.77 | Caffeine and insulin resistance in pregnancy. ( Catov, J; Laughon, SK; Parana, S; Powers, RW; Roberts, JM, 2011) |
| " Additionally, the mothers of these infants were asked to identify their smoking habits and/or caffeine consumption during pregnancy through face-to-face interviews." | 3.76 | A study on neonatal factors and eruption time of primary teeth. ( Aktoren, O; Gokcay, G; Guven, Y; Tuna, EB, 2010) |
| "We examined the associations of maternal caffeine intake, on the basis of coffee and tea consumption, with fetal growth characteristics measured in each trimester of pregnancy and the risks of adverse birth outcomes." | 3.76 | Maternal caffeine intake from coffee and tea, fetal growth, and the risks of adverse birth outcomes: the Generation R Study. ( Bakker, R; Hofman, A; Jaddoe, VW; Obradov, A; Raat, H; Steegers, EA, 2010) |
| "To examine the association of maternal caffeine intake with fetal growth restriction." | 3.74 | Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. ( , 2008) |
| " In comparison with not drinkers, all the ORs of overall intake of caffeine were closed near the unity for both SGA and NGA preterm birth." | 3.73 | Coffee drinking and risk of preterm birth. ( Chatenoud, L; Chiaffarino, F; Chiantera, V; Fedele, L; Maffioletti, C; Parazzini, F; Ricci, E; Tozzi, L, 2006) |
| "Apnea of prematurity develop during the first days of life and usually resolve by the time the infant reaches 36-37 weeks postmenstrual age." | 3.73 | [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate]. ( Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F, 2006) |
| "Whether caffeine consumption during pregnancy represents a fetal hazard remains uncertain." | 3.72 | Association of maternal caffeine consumption with decrements in fetal growth. ( Belanger, K; Bracken, MB; Hellenbrand, K; Leaderer, BP; Triche, EW, 2003) |
| "The aim of this study was to determine the effects of tobacco use and consumption of caffeine in pregnancy on the fetus and placenta by measuring the body weights, head circumferences, and lengths of newborns, and also weights and diameters of placentas." | 3.72 | The effect of smoking and caffeine on the fetus and placenta in pregnancy. ( Balat, A; Balat, O; Pençe, S; Ugur, MG, 2003) |
| "To test the hypothesis that, in women with type 1 diabetes, prenatal smoking and caffeine consumption during pregnancy are associated with an increased risk of adverse maternal and perinatal outcomes." | 3.72 | Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. ( Buncher, CR; Kalkwarf, H; Khoury, JC; Khoury, PR; McElvy, S; Miodovnik, M; Sibai, B, 2004) |
| "This study estimates the effect of maternal caffeine consumption throughout pregnancy on fetal growth." | 3.71 | Maternal caffeine intake and intrauterine growth retardation. ( Belanger, K; Bracken, MB; Grosso, LM; Leaderer, B; Rosenberg, KD; Saftlas, AF, 2001) |
| "Epidemiologic studies have been unable to conclusively evaluate whether caffeine intake during pregnancy is associated with reduced birth weight and/or fetal growth restriction." | 3.71 | Effect of caffeine exposure during pregnancy on birth weight and gestational age. ( Clausson, B; Cnattingius, S; Ekbom, A; Granath, F; Lundgren, S; Nordmark, A; Signorello, LB, 2002) |
| "2 weeks (range: 29-33 weeks), birth weight of 1400 +/- 380 g (range: 625-2060 g), and postnatal age of 24 to 72 hours before and 1 and 2 hours after an oral loading dose of 25 mg/kg pure caffeine." | 3.71 | Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. ( Beedgen, B; Hoecker, C; Linderkamp, O; Nelle, M; Poeschl, J, 2002) |
| "To assess the association between maternal caffeine consumption during pregnancy and low birth weight, prematurity and intrauterine growth retardation." | 3.71 | [Birthweight and caffeine consumption]. ( Barros Filho, Ade A; Bicalho, GG, 2002) |
| "The authors conducted a matched case-control study to investigate the effects of caffeine intake during pregnancy on birth weight." | 3.70 | Caffeine intake and low birth weight: a population-based case-control study. ( Carvalhal, JB; Huttly, S; Santos, IS; Victora, CG, 1998) |
| "Pregnant Yorkshire gilts (n = 42) were fed caffeine (6 g/d) or served as controls from d 60 of pregnancy until d 4 postpartum to test the effect of caffeine on mammary gland development, milk yield, and feed consumption." | 3.69 | The effect of caffeine on mammary gland development and milk yield in primiparous sows. ( Hacker, RR; Li, S, 1995) |
| " Alcohol and caffeine consumption by the mothers during pregnancy were both significantly associated with elevated IgE concentration." | 3.69 | Several genetic and environmental factors influence cord blood IgE concentration. ( Bjerke, T; Hedegaard, M; Henriksen, TB; Nielsen, BW; Schiøtz, PO, 1994) |
| "To examine the association of plasma caffeine concentrations during pregnancy with fetal growth and to compare this with relations with reported caffeine intake." | 3.69 | Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study. ( Anderson, HR; Bland, JM; Carey, IM; Cook, DG; Feyerabend, C; Jarvis, MJ; Peacock, JL, 1996) |
| "The aim of this study was to examine the effect of caffeine consumption during pregnancy on birth weight and its possible interaction with smoking." | 3.69 | Effect of caffeine intake during pregnancy on birth weight. ( Adanja, BJ; Marinković, JM; Petrović, RR; Sipetić, SB; Vlajinac, HD, 1997) |
| "Whether caffeine intake during pregnancy is related to intrauterine growth retardation, low birth weight, and preterm birth remains unclear." | 3.68 | Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth. ( Beaulac-Baillargeon, L; Fortier, I; Marcoux, S, 1993) |
| "The present study was designed to investigate the mechanism(s) underlying previously observed birth weight differences found in the first litter of the second (F2) generation bred from caffeine-exposed F1 females." | 3.68 | Caffeine-mediated effects on reproductive health over two generations in rats. ( Claassens, R; Pollard, I, 1992) |
| "To assess the prevalence of smoking and of caffeine and alcohol intake during pregnancy in a northern population and to determine the relation of these factors to birth weight, length and head circumference." | 3.68 | Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth. ( Froese, GJ; Godel, JC; Hodges, PE; Joffres, MR; Johnson, KE; Pabst, HF, 1992) |
| "Mice were administered caffeine (500 mg/liter of drinking water) from d 1 until d 18 of pregnancy." | 3.68 | Caffeine administered during pregnancy augments subsequent lactation in mice. ( Sheffield, LG, 1991) |
| "Taken together with studies reporting similar findings, these results suggest that heavy caffeine consumption increases the risk for fetal growth retardation." | 3.68 | Caffeine consumption during pregnancy and fetal growth. ( Eskenazi, B; Fenster, L; Swan, SH; Windham, GC, 1991) |
| "To investigate the effects of smoking, alcohol, and caffeine consumption and socio-economic factors and psychosocial stress on birth weight." | 3.67 | Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. ( Anderson, HR; Bland, JM; Brooke, OG; Peacock, JL; Stewart, CM, 1989) |
| "Caffeine, when administered in moderate (30 mg/kg X d) or high (60 mg/kg X d) doses during pregnancy, was shown to cause significant fetal growth retardation of both sexes." | 3.67 | Effects of caffeine administered during pregnancy on fetal development and subsequent function in the adult rat: prolonged effects on a second generation. ( Jabbour, H; Mehrabani, PA; Pollard, I, 1987) |
| "The influence of caffeine and cigarette consumption on fetal growth during pregnancy was studied retrospectively in 913 newborn infants." | 3.67 | Caffeine-cigarette interaction on fetal growth. ( Beaulac-Baillargeon, L; Desrosiers, C, 1987) |
| "To evaluate the relationship of antecedent maternal smoking and caffeine consumption habits on the occurrence of apnea in their offspring, rates for central and obstructive apnea were analyzed in a cohort of mother-infant pairs." | 3.67 | Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study. ( Bendell, D; Duke, JC; Mattice, CD; McCaffree, MA; Orr, WC; Toubas, PL, 1986) |
| "When caffeine (1,3,7-trimethylxanthine) was introduced into the diet of rats throughout pregnancy and lactation at levels of consumption of 10 mg/kg/day, offspring of successive pregnancies showed growth reductions." | 3.66 | Effects of maternal caffeine ingestion on neonatal growth in rats. ( Court, JM; Dunlop, M, 1981) |
| "Use of alcohol, caffeine, and nicotine during pregnancy can have serious consequences for the fetus, such as low birth weight, congenital anomalies, or even death." | 3.66 | Alcohol, caffeine, and nicotine as factors in pregnancy. ( Lodge, JR; Weathersbee, PS, 1979) |
| "Caffeine treatment is routinely used in premature infants to prevent development of apnea and bronchopulmonary dysplasia." | 3.30 | Effects of Different Onset Times of Early Caffeine Treatment on Mesenteric Tissue Oxygenation and Necrotizing Enterocolitis: A Prospective, Randomized Study. ( Cakir, SC; Cetinkaya, M; Koksal, N; Ozkan, H; Saglam, O, 2023) |
| " Further research into caffeine dosage and timing postpartum is required to establish its efficacy." | 1.56 | Caffeine supplementation at birth, but not 8 to 12 h post-birth, increased 24 h pre-weaning mortality in piglets. ( Hebart, ML; Kind, K; Nowland, TL; van Wettere, WHEJ, 2020) |
| "Caffeine exposure was associated to SGA (OR = 1." | 1.51 | Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome - results from the Norwegian Mother and Child Cohort Study. ( Bellocco, R; Brantsæter, AL; Elfvin, A; Jacobsson, B; Meltzer, HM; Modzelewska, D; Sengpiel, V, 2019) |
| "Caffeine intake was derived from coffee, tea, soft drinks, and cocoa-containing foods and beverages." | 1.48 | Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study. ( Chen, LW; Fitzgerald, R; Kelleher, CC; Mehegan, J; Murrin, CM; Phillips, CM, 2018) |
| "To identify dosing strategies that will assure stable caffeine concentrations in preterm neonates despite changing caffeine clearance during the first 8 weeks of life." | 1.46 | Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. ( Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J, 2017) |
| "19 children had OSAS (9." | 1.43 | Perinatal Risk Factors Associated with the Obstructive Sleep Apnea Syndrome in School-Aged Children Born Preterm. ( Cielo, CM; Doyle, LW; Marcus, CL; Nixon, GM; Shults, J; Tapia, IE; Traylor, J, 2016) |
| "Caffeine intake was consistently associated with decreased BW and increased odds of SGA." | 1.39 | Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. ( Alexander, J; Bacelis, J; Brantsaeter, AL; Elind, E; Grove, J; Haugen, M; Jacobsson, B; Meltzer, HM; Myhre, R; Nilsson, S; Sengpiel, V, 2013) |
| "Caffeine is a definite factor of intrauterine growth retardation (IUGR)." | 1.38 | A hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in offspring rats of IUGR induced by prenatal caffeine ingestion. ( Chen, LB; Lei, YY; Liu, F; Liu, J; Liu, YS; Magdalou, J; Ping, J; Qin, J; Shen, L; Wang, H; Wu, Y; Xu, D; Zhang, C, 2012) |
| "The caffeine base was administered orally as a loading dose of 10 mg/kg, followed by a maintenance dose of 2 mg/kg every 24 hours." | 1.31 | Caffeine metabolism in premature infants. ( al-Alaiyan, S; al-Rawithi, S; el-Yazigi, A; Legayada, E; Raines, D; Shoukri, MM; Yusuf, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (16.82) | 18.7374 |
| 1990's | 21 (19.63) | 18.2507 |
| 2000's | 18 (16.82) | 29.6817 |
| 2010's | 38 (35.51) | 24.3611 |
| 2020's | 12 (11.21) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt-Mehta, V | 1 |
| Schumacher, RE | 1 |
| Yang, T | 1 |
| Shen, Q | 1 |
| Wang, S | 1 |
| Dong, T | 1 |
| Liang, L | 1 |
| Xu, F | 1 |
| He, Y | 1 |
| Li, C | 1 |
| Luo, F | 1 |
| Liang, J | 1 |
| Tang, C | 1 |
| Yang, J | 1 |
| Lim, SY | 1 |
| May, CB | 1 |
| Johnson, PN | 1 |
| Miller, JL | 1 |
| Gur, EY | 1 |
| Cil, MA | 1 |
| Apay, SE | 1 |
| Moresco, L | 1 |
| Sjögren, A | 1 |
| Marques, KA | 1 |
| Soll, R | 1 |
| Bruschettini, M | 1 |
| Sanchez-Solis, M | 1 |
| Garcia-Marcos, PW | 1 |
| Agüera-Arenas, J | 1 |
| Mondejar-Lopez, P | 1 |
| Garcia-Marcos, L | 1 |
| Deng, L | 1 |
| Zhang, H | 1 |
| Song, L | 1 |
| Yu, K | 1 |
| Nowland, TL | 1 |
| Kind, K | 1 |
| Hebart, ML | 1 |
| van Wettere, WHEJ | 2 |
| Soltani, S | 1 |
| Askari, M | 1 |
| Larijani, B | 1 |
| Azadbakht, L | 1 |
| Esmaillzadeh, A | 1 |
| Gleason, JL | 1 |
| Tekola-Ayele, F | 1 |
| Sundaram, R | 1 |
| Hinkle, SN | 1 |
| Vafai, Y | 1 |
| Buck Louis, GM | 1 |
| Gerlanc, N | 1 |
| Amyx, M | 1 |
| Bever, AM | 1 |
| Smarr, MM | 1 |
| Robinson, M | 1 |
| Kannan, K | 1 |
| Grantz, KL | 1 |
| Ozkan, H | 1 |
| Cetinkaya, M | 1 |
| Cakir, SC | 1 |
| Saglam, O | 1 |
| Koksal, N | 1 |
| Sasaki, S | 1 |
| Limpar, M | 1 |
| Sata, F | 1 |
| Kobayashi, S | 1 |
| Kishi, R | 1 |
| Schmidt, B | 1 |
| Roberts, RS | 1 |
| Anderson, PJ | 1 |
| Asztalos, EV | 1 |
| Costantini, L | 1 |
| Davis, PG | 1 |
| Dewey, D | 1 |
| D'Ilario, J | 1 |
| Doyle, LW | 2 |
| Grunau, RE | 1 |
| Moddemann, D | 1 |
| Nelson, H | 1 |
| Ohlsson, A | 1 |
| Solimano, A | 1 |
| Tin, W | 1 |
| Jobe, AH | 1 |
| Koch, G | 1 |
| Datta, AN | 1 |
| Jost, K | 1 |
| Schulzke, SM | 1 |
| van den Anker, J | 1 |
| Pfister, M | 1 |
| Sharma, SS | 1 |
| Greenwood, DC | 2 |
| Simpson, NAB | 1 |
| Cade, JE | 2 |
| Hwang, J | 1 |
| Kim, YS | 1 |
| Shin, JH | 1 |
| Choi, BM | 1 |
| Peacock, A | 1 |
| Hutchinson, D | 1 |
| Wilson, J | 1 |
| McCormack, C | 1 |
| Bruno, R | 1 |
| Olsson, CA | 1 |
| Allsop, S | 1 |
| Elliott, E | 1 |
| Burns, L | 1 |
| Mattick, RP | 1 |
| Dearlove, BA | 1 |
| Kind, KL | 1 |
| Gatford, KL | 1 |
| Chen, LW | 2 |
| Fitzgerald, R | 1 |
| Murrin, CM | 1 |
| Mehegan, J | 1 |
| Kelleher, CC | 1 |
| Phillips, CM | 1 |
| Modzelewska, D | 1 |
| Bellocco, R | 1 |
| Elfvin, A | 1 |
| Brantsæter, AL | 1 |
| Meltzer, HM | 2 |
| Jacobsson, B | 2 |
| Sengpiel, V | 2 |
| Kou, C | 1 |
| Han, D | 1 |
| Li, Z | 1 |
| Wu, W | 1 |
| Liu, Z | 1 |
| Zhang, Y | 1 |
| Gao, Z | 1 |
| Ali, Z | 1 |
| Schmidt, P | 1 |
| Dodd, J | 1 |
| Jeppesen, DL | 1 |
| Elind, E | 1 |
| Bacelis, J | 1 |
| Nilsson, S | 1 |
| Grove, J | 1 |
| Myhre, R | 1 |
| Haugen, M | 1 |
| Alexander, J | 1 |
| Brantsaeter, AL | 1 |
| Jahanfar, S | 3 |
| Jaafar, SH | 2 |
| Triche, EW | 2 |
| Lundsberg, LS | 1 |
| Hollins Martin, C | 1 |
| Broom, M | 1 |
| Ying, L | 1 |
| Wright, A | 1 |
| Stewart, A | 1 |
| Abdel-Latif, ME | 1 |
| Shadbolt, B | 1 |
| Todd, DA | 1 |
| Sun, T | 1 |
| Guo, J | 1 |
| Chen, H | 1 |
| Zhang, J | 1 |
| Zhang, X | 1 |
| Jiang, X | 1 |
| Wang, F | 1 |
| Xu, Z | 1 |
| Huang, X | 1 |
| Sha, J | 1 |
| Chan, HC | 1 |
| Kreutzer, K | 1 |
| Bassler, D | 1 |
| Thatcher, NJ | 1 |
| Ye, J | 1 |
| Garrard, L | 1 |
| Keogh, G | 1 |
| King, LG | 1 |
| Wu, Y | 2 |
| Neelakantan, N | 1 |
| Chong, MF | 1 |
| Pan, A | 1 |
| van Dam, RM | 1 |
| Bracken, MB | 4 |
| James, JE | 1 |
| Rhee, J | 1 |
| Kim, R | 1 |
| Kim, Y | 1 |
| Tam, M | 1 |
| Lai, Y | 1 |
| Keum, N | 1 |
| Oldenburg, CE | 1 |
| Tapia, IE | 1 |
| Shults, J | 1 |
| Nixon, GM | 1 |
| Cielo, CM | 1 |
| Traylor, J | 1 |
| Marcus, CL | 1 |
| Partosch, F | 1 |
| Mielke, H | 1 |
| Stahlmann, R | 1 |
| Gundert-Remy, U | 1 |
| Del Castillo, N | 1 |
| Jiménez-Moleón, JJ | 1 |
| Olmedo-Requena, R | 1 |
| Martínez-Ruiz, V | 1 |
| Bueno-Cavanillas, A | 1 |
| Mozas, J | 1 |
| Cox, C | 1 |
| Hashem, NG | 1 |
| Tebbs, J | 1 |
| Bookstaver, PB | 1 |
| Iskersky, V | 1 |
| Zhao, Y | 1 |
| Tian, X | 1 |
| Liu, G | 1 |
| Voerman, E | 1 |
| Jaddoe, VW | 2 |
| Gishti, O | 1 |
| Hofman, A | 2 |
| Franco, OH | 1 |
| Gaillard, R | 1 |
| Adams, T | 1 |
| Kelsberg, G | 1 |
| Safranek, S | 1 |
| Powell, MB | 1 |
| Ahlers-Schmidt, CR | 1 |
| Engel, M | 1 |
| Bloom, BT | 1 |
| Sharifah, H | 1 |
| Aktoren, O | 1 |
| Tuna, EB | 1 |
| Guven, Y | 1 |
| Gokcay, G | 1 |
| Bakker, R | 1 |
| Steegers, EA | 1 |
| Obradov, A | 1 |
| Raat, H | 1 |
| Laughon, SK | 1 |
| Powers, RW | 1 |
| Roberts, JM | 1 |
| Parana, S | 1 |
| Catov, J | 1 |
| Jarosz, M | 1 |
| Wierzejska, R | 1 |
| Siuba, M | 1 |
| Patel, P | 1 |
| Mulla, H | 1 |
| Kairamkonda, V | 1 |
| Spooner, N | 1 |
| Gade, S | 1 |
| Della Pasqua, O | 1 |
| Field, DJ | 1 |
| Pandya, HC | 1 |
| Xu, D | 1 |
| Liu, F | 1 |
| Liu, YS | 1 |
| Shen, L | 1 |
| Lei, YY | 1 |
| Liu, J | 1 |
| Ping, J | 1 |
| Qin, J | 1 |
| Zhang, C | 1 |
| Chen, LB | 1 |
| Magdalou, J | 1 |
| Wang, H | 1 |
| Belanger, K | 2 |
| Hellenbrand, K | 1 |
| Leaderer, BP | 1 |
| Balat, O | 1 |
| Balat, A | 1 |
| Ugur, MG | 1 |
| Pençe, S | 1 |
| WINBERG, J | 1 |
| Chardon, K | 1 |
| Bach, V | 1 |
| Telliez, F | 1 |
| Cardot, V | 1 |
| Tourneux, P | 1 |
| Leke, A | 1 |
| Libert, JP | 1 |
| Khoury, JC | 1 |
| Miodovnik, M | 1 |
| Buncher, CR | 1 |
| Kalkwarf, H | 1 |
| McElvy, S | 1 |
| Khoury, PR | 1 |
| Sibai, B | 1 |
| Chiaffarino, F | 1 |
| Parazzini, F | 1 |
| Chatenoud, L | 1 |
| Ricci, E | 1 |
| Tozzi, L | 1 |
| Chiantera, V | 1 |
| Maffioletti, C | 1 |
| Fedele, L | 1 |
| Havranek, T | 1 |
| Thompson, Z | 1 |
| Carver, JD | 1 |
| Ducrocq, S | 1 |
| Biran-Mucignat, V | 1 |
| Boelle, PY | 1 |
| Lebas, F | 1 |
| Baudon, JJ | 1 |
| Gold, F | 1 |
| Bech, BH | 1 |
| Obel, C | 1 |
| Henriksen, TB | 2 |
| Olsen, J | 1 |
| Hey, E | 1 |
| Henderson, GI | 1 |
| Schenker, S | 1 |
| Kuzma, JW | 1 |
| Sokol, RJ | 1 |
| Dews, PB | 1 |
| Aeschbacher, HU | 1 |
| Milon, H | 1 |
| Poot, A | 1 |
| Würzner, HP | 1 |
| Dunlop, M | 1 |
| Court, JM | 1 |
| Soyka, LF | 1 |
| Neese, AL | 1 |
| Main, D | 1 |
| Main, E | 1 |
| Li, S | 1 |
| Hacker, RR | 1 |
| Shu, XO | 1 |
| Hatch, MC | 1 |
| Mills, J | 1 |
| Clemens, J | 1 |
| Susser, M | 1 |
| Bjerke, T | 1 |
| Hedegaard, M | 1 |
| Nielsen, BW | 1 |
| Schiøtz, PO | 1 |
| Larroque, B | 1 |
| Kaminski, M | 1 |
| Lelong, N | 1 |
| Subtil, D | 1 |
| Dehaene, P | 1 |
| Fortier, I | 1 |
| Marcoux, S | 1 |
| Beaulac-Baillargeon, L | 2 |
| Shiono, PH | 1 |
| Klebanoff, MA | 1 |
| Beck, SL | 1 |
| Urbano, CM | 1 |
| Cook, DG | 1 |
| Peacock, JL | 3 |
| Feyerabend, C | 1 |
| Carey, IM | 1 |
| Jarvis, MJ | 1 |
| Anderson, HR | 3 |
| Bland, JM | 3 |
| Vlajinac, HD | 1 |
| Petrović, RR | 1 |
| Marinković, JM | 1 |
| Sipetić, SB | 1 |
| Adanja, BJ | 1 |
| Makowiec-Dabrowska, T | 1 |
| Siedlecka, J | 1 |
| Radwan-Włodarczyk, Z | 1 |
| Koszada-Włodarczyk, W | 1 |
| Wilczyński, J | 1 |
| Karthikeyan, G | 1 |
| Santos, IS | 1 |
| Victora, CG | 1 |
| Huttly, S | 1 |
| Carvalhal, JB | 1 |
| Eskenazi, B | 2 |
| Stapleton, AL | 1 |
| Kharrazi, M | 1 |
| Chee, WY | 1 |
| Poets, CF | 1 |
| Darraj, S | 1 |
| Bohnhorst, B | 1 |
| Dani, C | 1 |
| Bertini, G | 1 |
| Reali, MF | 1 |
| Tronchin, M | 1 |
| Wiechmann, L | 1 |
| Martelli, E | 1 |
| Rubaltelli, FF | 1 |
| al-Alaiyan, S | 1 |
| al-Rawithi, S | 1 |
| Raines, D | 1 |
| Yusuf, A | 1 |
| Legayada, E | 1 |
| Shoukri, MM | 1 |
| el-Yazigi, A | 1 |
| Grosso, LM | 1 |
| Rosenberg, KD | 1 |
| Saftlas, AF | 1 |
| Leaderer, B | 1 |
| Clausson, B | 1 |
| Granath, F | 1 |
| Ekbom, A | 1 |
| Lundgren, S | 1 |
| Nordmark, A | 1 |
| Signorello, LB | 1 |
| Cnattingius, S | 1 |
| Hoecker, C | 1 |
| Nelle, M | 1 |
| Poeschl, J | 1 |
| Beedgen, B | 1 |
| Linderkamp, O | 1 |
| Bicalho, GG | 1 |
| Barros Filho, Ade A | 1 |
| Weathersbee, PS | 1 |
| Lodge, JR | 1 |
| Pollard, I | 2 |
| Claassens, R | 1 |
| Dar, E | 1 |
| Kanarek, MS | 1 |
| Anderson, HA | 1 |
| Sonzogni, WC | 1 |
| Godel, JC | 1 |
| Pabst, HF | 1 |
| Hodges, PE | 1 |
| Johnson, KE | 1 |
| Froese, GJ | 1 |
| Joffres, MR | 1 |
| Sheffield, LG | 1 |
| Fenster, L | 1 |
| Windham, GC | 1 |
| Swan, SH | 1 |
| Brooke, OG | 1 |
| Stewart, CM | 1 |
| Gilbert, SG | 1 |
| Rice, DC | 1 |
| Reuhl, KR | 1 |
| Stavric, B | 1 |
| Jabbour, H | 1 |
| Mehrabani, PA | 1 |
| Martin, TR | 1 |
| Desrosiers, C | 1 |
| Toubas, PL | 1 |
| Duke, JC | 1 |
| McCaffree, MA | 1 |
| Mattice, CD | 1 |
| Bendell, D | 1 |
| Orr, WC | 1 |
| Winick, M | 1 |
| Hebel, JR | 1 |
| Nowicki, P | 1 |
| Sexton, M | 1 |
| Mau, G | 1 |
| Netter, P | 1 |
| Gilbert, EF | 1 |
| Pistey, WR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants[NCT00182312] | Phase 3 | 2,000 participants (Anticipated) | Interventional | 1999-10-31 | Completed | ||
| Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
| High Versus Low Dose Caffeine as Respiratory Stimulant in Preterm Infants[NCT04144712] | Phase 1 | 80 participants (Anticipated) | Interventional | 2019-04-01 | Recruiting | ||
| The Importance of Caffeine in Fetal Growth[NCT00131690] | Phase 4 | 1,200 participants | Interventional | 1996-04-30 | Completed | ||
| A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates[NCT03086473] | Phase 4 | 24 participants (Actual) | Interventional | 2017-02-01 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for caffeine and Birth Weight
| Article | Year |
|---|---|
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
Topics: Aminophylline; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Hearing Loss; Humans; Infa | 2023 |
Bronchopulmonary dysplasia: a review.
Topics: Adrenal Cortex Hormones; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Female; Gestational Age | 2013 |
Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome.
Topics: Birth Weight; Caffeine; Central Nervous System Stimulants; Coffee; Female; Humans; Pregnancy; Pregna | 2013 |
Caffeine for apnea of prematurity: a neonatal success story.
Topics: Animals; Apnea; Birth Weight; Caffeine; Cost-Benefit Analysis; Drug Costs; Gestational Age; Humans; | 2014 |
Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis.
Topics: Abortion, Spontaneous; Birth Weight; Caffeine; Female; Humans; Infant, Small for Gestational Age; Pr | 2014 |
Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis.
Topics: Birth Weight; Caffeine; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Pregnancy; | 2014 |
Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes.
Topics: Birth Weight; Caffeine; Central Nervous System Stimulants; Coffee; Female; Humans; Infant, Newborn; | 2015 |
Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies.
Topics: Birth Weight; Caffeine; Coffee; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Pregnancy | 2015 |
Clinical Inquiry: Does caffeine intake during pregnancy affect birth weight?
Topics: Adult; Birth Weight; Caffeine; Coffee; Cohort Studies; Dose-Response Relationship, Drug; Female; Ges | 2016 |
Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome.
Topics: Birth Weight; Caffeine; Central Nervous System Stimulants; Coffee; Female; Humans; Pregnancy; Pregna | 2009 |
Caffeine.
Topics: Adult; Age Factors; Animals; Behavior, Animal; Birth Weight; Caffeine; Cardiovascular System; Centra | 1982 |
11 trials available for caffeine and Birth Weight
| Article | Year |
|---|---|
Effects of Different Onset Times of Early Caffeine Treatment on Mesenteric Tissue Oxygenation and Necrotizing Enterocolitis: A Prospective, Randomized Study.
Topics: Birth Weight; Caffeine; Enterocolitis, Necrotizing; Female; Fetal Diseases; Humans; Infant; Infant, | 2023 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Oral caffeine administered during late gestation increases gestation length and piglet temperature in naturally farrowing sows.
Topics: Administration, Oral; Animals; Animals, Newborn; Birth Weight; Body Temperature; Caffeine; Drug Admi | 2018 |
Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Topics: Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrat | 2020 |
CeasIng Cpap At standarD criteriA (CICADA): impact on weight gain, time to full feeds and caffeine use.
Topics: Apgar Score; Birth Weight; Caffeine; Continuous Positive Airway Pressure; Drug Administration Schedu | 2014 |
[Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Topics: Apnea; Birth Weight; Caffeine; Citrates; Female; Gestational Age; Humans; Infant, Newborn; Infant, P | 2016 |
Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial.
Topics: Adult; Birth Weight; Caffeine; Coffee; Double-Blind Method; Female; Gestational Age; Humans; Materna | 2007 |
Caffeine and fetal growth.
Topics: Birth Weight; Caffeine; Chromatography, Gas; Embryonic and Fetal Development; Female; Gestational Ag | 1997 |
Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
Topics: Apnea; Birth Weight; Bradycardia; Caffeine; Doxapram; Drug Resistance; Gestational Age; Humans; Hypo | 1999 |
Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment.
Topics: Aminophylline; Apnea; Birth Weight; Blood Flow Velocity; Blood Volume; Caffeine; Central Nervous Sys | 2000 |
The effect of antismoking intervention during pregnancy: an assessment of interactions with maternal characteristics.
Topics: Adolescent; Adult; Alcohol Drinking; Birth Weight; Caffeine; Educational Status; Female; Health Prom | 1985 |
85 other studies available for caffeine and Birth Weight
| Article | Year |
|---|---|
The effect of ibuprofen and caffeine prophylaxis on retinopathy of prematurity.
Topics: Birth Weight; Caffeine; Gestational Age; Humans; Ibuprofen; Infant, Newborn; Infant, Very Low Birth | 2021 |
Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
Topics: Adult; Aminophylline; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Ductus Arteriosus, Patent; | 2022 |
Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Gestational Age; Humans; Infant; Infant, Newborn | 2023 |
The caffeine consumption among Turkish pregnant women.
Topics: Birth Weight; Caffeine; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Pregnancy; Pregna | 2022 |
Impact of early caffeine therapy in preterm newborns on infant lung function.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Female; Force | 2020 |
Approximation of bias and mean-squared error in two-sample Mendelian randomization analyses.
Topics: Bias; Biometry; Birth Weight; Caffeine; Causality; Computer Simulation; Female; Fetal Macrosomia; Ge | 2020 |
Caffeine supplementation at birth, but not 8 to 12 h post-birth, increased 24 h pre-weaning mortality in piglets.
Topics: Animals; Animals, Newborn; Birth Weight; Caffeine; Dietary Supplements; Female; Humans; Parturition; | 2020 |
Careful data extraction in meta-analysis: the case of maternal caffeine intake during pregnancy and low-birth weight, childhood overweight, and obesity.
Topics: Birth Weight; Caffeine; Child; Eating; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Pe | 2021 |
Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons.
Topics: Adult; Anthropometry; Biomarkers; Birth Weight; Caffeine; Female; Fetal Development; Follow-Up Studi | 2021 |
Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.
Topics: Alcohol Drinking; Birth Weight; Caffeine; Cohort Studies; Cytochrome P-450 CYP1A2; Female; Genotype; | 2017 |
Caffeine: A Lung Drug for All Very Low Birth Weight Preterm Infants?
Topics: Birth Weight; Caffeine; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant | 2017 |
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationsh | 2017 |
Is dietary macronutrient composition during pregnancy associated with offspring birth weight? An observational study.
Topics: Adult; Alcohol Drinking; Birth Weight; Body Mass Index; Caffeine; Diet; Diet Records; Dietary Carboh | 2018 |
Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.
Topics: Administration, Intravenous; Birth Weight; Caffeine; Citrates; Ductus Arteriosus; Ductus Arteriosus, | 2018 |
Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort Study.
Topics: Adult; Australia; Birth Weight; Caffeine; Female; Fetal Development; Follow-Up Studies; Humans; Infa | 2018 |
Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study.
Topics: Adult; Alcohol Drinking; Birth Weight; Caffeine; Cigarette Smoking; Coffee; Cohort Studies; Diet; Fe | 2018 |
Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome - results from the Norwegian Mother and Child Cohort Study.
Topics: Adult; Birth Weight; Caffeine; Cohort Studies; Female; Gestational Age; Humans; Infant, Low Birth We | 2019 |
Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study.
Topics: Adult; Birth Weight; Caffeine; Cohort Studies; Diet; Female; Humans; Norway; Pregnancy; Premature Bi | 2013 |
Caffeine is modestly associated with lower birth weight and fetal growth.
Topics: Birth Weight; Caffeine; Diet; Female; Humans; Pregnancy; Premature Birth | 2014 |
Higher coffee intake in pregnancy linked to prolonged gestation, and higher caffeine intake linked with babies being small for gestational age.
Topics: Birth Weight; Caffeine; Diet; Female; Humans; Pregnancy; Premature Birth | 2014 |
Maternal caffeine exposure impairs insulin secretion by pancreatic β-cells and increases the risk of type II diabetes mellitus in offspring.
Topics: Animals; Apoptosis; Birth Weight; Blood Glucose; Caffeine; Cells, Cultured; Diabetes Mellitus, Type | 2014 |
Potential confounding still clouds the possible association of maternal caffeine intake and low birth weight.
Topics: Birth Weight; Caffeine; Female; Humans; Infant, Low Birth Weight; Male; Pregnancy; Prenatal Exposure | 2015 |
Review: higher caffeine intake during pregnancy increases risk of low birth weight.
Topics: Birth Weight; Caffeine; Female; Humans; Infant, Low Birth Weight; Male; Pregnancy; Prenatal Exposure | 2015 |
Perinatal Risk Factors Associated with the Obstructive Sleep Apnea Syndrome in School-Aged Children Born Preterm.
Topics: Apgar Score; Birth Weight; Caffeine; Child; Child, Preschool; Chorioamnionitis; Cohort Studies; Doub | 2016 |
Caffeine intake in pregnancy: Relationship between internal intake and effect on birth weight.
Topics: Adult; Birth Weight; Caffeine; Computer Simulation; Female; Humans; Infant, Newborn; Models, Biologi | 2015 |
PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION.
Topics: Adult; Birth Weight; Caffeine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hu | 2015 |
Evaluation of caffeine and the development of necrotizing enterocolitis.
Topics: Birth Weight; Caffeine; Central Nervous System Stimulants; Enterocolitis, Necrotizing; Female; Gesta | 2015 |
Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age.
Topics: Birth Weight; Body Composition; Body Fat Distribution; Body Mass Index; Caffeine; Child; Coffee; Fem | 2016 |
Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management.
Topics: Apnea; Birth Weight; Caffeine; Disease Management; Female; Gestational Age; Humans; Infant; Infant, | 2017 |
Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study.
Topics: Adolescent; Adult; Birth Weight; Caffeine; Cotinine; Female; Fetal Growth Retardation; Gestational A | 2008 |
A study on neonatal factors and eruption time of primary teeth.
Topics: Birth Weight; Caffeine; Child, Preschool; Female; Gestational Age; Humans; Infant; Infant, Newborn; | 2010 |
Maternal caffeine intake from coffee and tea, fetal growth, and the risks of adverse birth outcomes: the Generation R Study.
Topics: Adolescent; Adult; Birth Weight; Caffeine; Coffee; Cohort Studies; Dose-Response Relationship, Drug; | 2010 |
Caffeine and insulin resistance in pregnancy.
Topics: Birth Weight; Caffeine; Female; Homeostasis; Humans; Infant, Newborn; Insulin Resistance; Male; Preg | 2011 |
Maternal caffeine intake and its effect on pregnancy outcomes.
Topics: Adolescent; Adult; Age Factors; Apgar Score; Beverages; Birth Weight; Caffeine; Female; Fetal Develo | 2012 |
Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Agents; Dried Blood Spot Testing; Female; Gest | 2013 |
A hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in offspring rats of IUGR induced by prenatal caffeine ingestion.
Topics: Animals; Birth Weight; Blood Glucose; Caffeine; Female; Fetal Growth Retardation; Hippocampus; Hypot | 2012 |
Association of maternal caffeine consumption with decrements in fetal growth.
Topics: Adult; Birth Weight; Caffeine; Confounding Factors, Epidemiologic; Connecticut; Female; Fetal Growth | 2003 |
The effect of smoking and caffeine on the fetus and placenta in pregnancy.
Topics: Anthropometry; Birth Weight; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship | 2003 |
[ANALYSIS OF THE POSSIBLE RELATION OF FETAL DAMAGE AND DRUGS. V. PRELIMINARY STUDY ON THE INFLUENCE OF 4 ANTIEMETICS ON FETAL DEVELOPMENT].
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Antiemetics; Birth Weight; Ca | 1964 |
Effect of caffeine on peripheral chemoreceptor activity in premature neonates: interaction with sleep stages.
Topics: Birth Weight; Body Temperature; Caffeine; Chemoreceptor Cells; Gestational Age; Humans; Infant; Infa | 2004 |
Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes.
Topics: Abortion, Spontaneous; Adult; Birth Weight; Caffeine; Diabetes Mellitus, Type 1; Female; Humans; Pre | 2004 |
Coffee drinking and risk of preterm birth.
Topics: Adolescent; Adult; Birth Weight; Caffeine; Case-Control Studies; Coffee; Female; Humans; Infant, New | 2006 |
Factors that influence mesenteric artery blood flow velocity in newborn preterm infants.
Topics: Birth Weight; Blood Flow Velocity; Caffeine; Continuous Positive Airway Pressure; Enteral Nutrition; | 2006 |
[Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Topics: Ambulatory Care; Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Continu | 2006 |
Coffee and pregnancy.
Topics: Birth Weight; Caffeine; Coffee; Female; Humans; Pregnancy; Pregnancy Complications | 2007 |
Diet & nutrition. Good news: caffeine in pregnancy doesn't affect the baby's growth...and folic acid seems to prevent cleft lip.
Topics: Birth Weight; Caffeine; Central Nervous System Stimulants; Cleft Lip; Coffee; Female; Fetal Developm | 2007 |
Effects of ethanol and/or caffeine on fetal development and placental amino acid uptake in rats.
Topics: Amino Acids; Aminoisobutyric Acids; Animals; Birth Weight; Body Weight; Caffeine; Diet; Ethanol; Fem | 1984 |
Maternal drinking behavior and decreased intrauterine growth.
Topics: Adult; Alcohol Drinking; Birth Weight; Caffeine; Female; Fetal Growth Retardation; Humans; Maternal- | 1982 |
Effect of caffeine on rat offspring from treated dams.
Topics: Animals; Birth Weight; Caffeine; Female; Fetus; Milk; Pregnancy; Rats; Rats, Inbred Strains | 1980 |
Effects of maternal caffeine ingestion on neonatal growth in rats.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Birth Weight; Body Weight; Caffeine; Female; | 1981 |
Studies of caffeine and theophylline in the neonate.
Topics: Aminophylline; Amniotic Fluid; Birth Weight; Blood Transfusion; Caffeine; Fetal Blood; Fetus; Gestat | 1981 |
The effect of caffeine on mammary gland development and milk yield in primiparous sows.
Topics: Aging; Animals; Animals, Suckling; Birth Weight; Caffeine; DNA; Eating; Female; Lactation; Mammary G | 1995 |
Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study.
Topics: Adult; Alcohol Drinking; Birth Weight; Caffeine; Coffee; Embryonic and Fetal Development; Ethanol; F | 1995 |
Several genetic and environmental factors influence cord blood IgE concentration.
Topics: Alcohol Drinking; Birth Weight; Caffeine; Female; Fetal Blood; Humans; Hypersensitivity, Immediate; | 1994 |
Effects of birth weight of alcohol and caffeine consumption during pregnancy.
Topics: Birth Weight; Caffeine; Ethanol; Female; Gestational Age; Humans; Infant, Newborn; Maternal Age; Mat | 1993 |
Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth.
Topics: Adult; Birth Weight; Cacao; Caffeine; Coffee; Educational Status; Female; Fetal Growth Retardation; | 1993 |
Invited commentary: caffeine and birth outcomes.
Topics: Birth Weight; Caffeine; Confounding Factors, Epidemiologic; Female; Fetal Growth Retardation; Gestat | 1993 |
Acetazolamide with caffeine causes exencephaly in "resistant" SWV mice.
Topics: Acetazolamide; Animals; Birth Weight; Brain; Caffeine; Cervical Vertebrae; Embryo, Mammalian; Female | 1993 |
Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study.
Topics: Beverages; Birth Weight; Cacao; Caffeine; Carbonated Beverages; Coffee; Drinking; Embryonic and Feta | 1996 |
Effect of caffeine intake during pregnancy on birth weight.
Topics: Birth Weight; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Coffee; Confounding | 1997 |
Reproductive toxicology. Caffeine.
Topics: Animals; Birth Weight; Body Weight; Caffeine; Dose-Response Relationship, Drug; Female; Litter Size; | 1997 |
[The effect of mothers' occupation on body mass of newborns born at term].
Topics: Abortion, Spontaneous; Adult; Birth Weight; Caffeine; Female; Health Status; Humans; Incidence; Infa | 1997 |
Caffeine intake and low birth weight: a population-based case-control study.
Topics: Beverages; Birth Weight; Caffeine; Case-Control Studies; Coffee; Female; Fetal Growth Retardation; G | 1998 |
Associations between maternal decaffeinated and caffeinated coffee consumption and fetal growth and gestational duration.
Topics: Adult; Birth Weight; Caffeine; California; Coffee; Diet Surveys; Embryonic and Fetal Development; Fe | 1999 |
Caffeine metabolism in premature infants.
Topics: Age Factors; Birth Weight; Body Weight; Caffeine; Central Nervous System Stimulants; Female; Gestati | 2001 |
Maternal caffeine intake and intrauterine growth retardation.
Topics: Adult; Birth Weight; Caffeine; Central Nervous System Stimulants; Cohort Studies; Female; Fetal Grow | 2001 |
Effect of caffeine exposure during pregnancy on birth weight and gestational age.
Topics: Adult; Birth Weight; Caffeine; Central Nervous System Stimulants; Cohort Studies; Female; Fetal Grow | 2002 |
Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants.
Topics: Administration, Oral; Birth Weight; Blood Flow Velocity; Blood Pressure; Caffeine; Celiac Artery; Ce | 2002 |
[Birthweight and caffeine consumption].
Topics: Adult; Birth Weight; Caffeine; Case-Control Studies; Female; Fetal Growth Retardation; Gestational A | 2002 |
Alcohol, caffeine, and nicotine as factors in pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Alcohol Drinking; Animals; Birth Weight; Caffe | 1979 |
Caffeine-mediated effects on reproductive health over two generations in rats.
Topics: Animals; Birth Weight; Caffeine; Cohort Effect; Dose-Response Relationship, Drug; Female; Labor, Obs | 1992 |
Fish consumption and reproductive outcomes in Green Bay, Wisconsin.
Topics: Adolescent; Adult; Alcohol Drinking; Animals; Birth Weight; Caffeine; Female; Fish Products; Fishes; | 1992 |
Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth.
Topics: Adolescent; Adult; Alcohol Drinking; Analysis of Variance; Birth Weight; Body Height; Caffeine; Ceph | 1992 |
Caffeine administered during pregnancy augments subsequent lactation in mice.
Topics: Animals; Birth Weight; Caffeine; Cell Count; DNA; Female; Lactation; Litter Size; Mammary Glands, An | 1991 |
Caffeine consumption during pregnancy and fetal growth.
Topics: Adult; Birth Weight; Caffeine; Case-Control Studies; Female; Fetal Growth Retardation; Humans; Infan | 1991 |
Effects on birthweight of alcohol and caffeine consumption in smoking women.
Topics: Alcohol Drinking; Birth Weight; Caffeine; Embryonic and Fetal Development; Ethanol; Female; Humans; | 1991 |
Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress.
Topics: Adolescent; Adult; Alcohol Drinking; Birth Weight; Caffeine; Coffee; Female; Gestational Age; Humans | 1989 |
Adverse pregnancy outcome in the monkey (Macaca fascicularis) after chronic caffeine exposure.
Topics: Abortion, Veterinary; Animals; Birth Weight; Body Weight; Caffeine; Female; Fetal Death; Macaca fasc | 1988 |
Effects of caffeine administered during pregnancy on fetal development and subsequent function in the adult rat: prolonged effects on a second generation.
Topics: 3-Hydroxysteroid Dehydrogenases; Abnormalities, Drug-Induced; Animals; Birth Weight; Caffeine; Embry | 1987 |
The association between low birth weight and caffeine consumption during pregnancy.
Topics: Adult; Birth Weight; Caffeine; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Lo | 1987 |
Caffeine-cigarette interaction on fetal growth.
Topics: Birth Weight; Caffeine; Embryonic and Fetal Development; Female; Gestational Age; Humans; Infant, Ne | 1987 |
Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study.
Topics: Apnea; Birth Weight; Caffeine; Female; Humans; Infant, Newborn; Maternal Age; Pregnancy; Prenatal Ex | 1986 |
Environmental factors affecting fetal growth.
Topics: Animals; Birth Weight; Body Weight; Caffeine; Coffee; Embryonic and Fetal Development; Ethanol; Fema | 1985 |
[Are coffee and alcohol consumption risk factors in pregnancy? (author's transl)].
Topics: Age Factors; Alcohol Drinking; Birth Weight; Body Weight; Caffeine; Coffee; Ethanol; Female; Fetal D | 1974 |
Effect on the offspring of repeated caffeine administration to pregnant rats.
Topics: Animals; Birth Weight; Caffeine; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Fetal | 1973 |